TrialThe Lancet. Infectious diseases2012

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Merlin L Robb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.